1449P The preliminary data from a single-arm, open-label, multicenter phase II clinical trial: KN046 combined with axitinib as first-line (1L) treatment for NSCLC
Annals of Oncology(2023)
关键词
nsclc,axitinib,clinical trial,treatment,single-arm,open-label,first-line
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要